A systematic review of live vaccine outcomes in infants exposed to biologic disease modifying anti-rheumatic drugs in utero
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A systematic review of live vaccine outcomes in infants exposed to biologic disease modifying anti-rheumatic drugs in utero
Authors
Keywords
-
Journal
RHEUMATOLOGY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2022-03-05
DOI
10.1093/rheumatology/keac141
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Analysing cord blood levels of TNF inhibitors to validate the EULAR points to consider for TNF inhibitor use during pregnancy
- (2021) Nafise Ghalandari et al. ANNALS OF THE RHEUMATIC DISEASES
- 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases
- (2020) Lisa R. Sammaritano et al. ARTHRITIS CARE & RESEARCH
- Safety and optimal timing of BCG vaccination in infants born to mothers receiving anti-TNF therapy for inflammatory bowel disease
- (2020) Sang Hyoung Park et al. Journal of Crohns & Colitis
- Use of biologic therapies for psoriasis during pregnancy and long‐term outcomes of exposed children: A 14‐year real‐life experience at a tertiary center in Turkey and review of the literature
- (2020) Goncagul Babuna Kobaner et al. Dermatologic Therapy
- Placental transfer of tocilizumab in a patient with rheumatoid arthritis
- (2019) Yoshifumi Tada et al. RHEUMATOLOGY
- Safety of first year vaccination in children born to mothers with inflammatory bowel disease and exposed in utero to anti-TNFα agents: a French nationwide population-based cohort
- (2019) Maxime Luu et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines
- (2018) Dawn B. Beaulieu et al. Clinical Gastroenterology and Hepatology
- Tocilizumab concentrations in maternal serum and breast milk during breastfeeding and a safety assessment in infants: a case study
- (2018) Jumpei Saito et al. RHEUMATOLOGY
- Factors Affecting the FcRn-Mediated Transplacental Transfer of Antibodies and Implications for Vaccination in Pregnancy
- (2017) Christopher R. Wilcox et al. Frontiers in Immunology
- Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection
- (2016) Mette Julsgaard et al. GASTROENTEROLOGY
- BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding—Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids: Table 1
- (2016) Julia Flint et al. RHEUMATOLOGY
- Impact of Anti–Tumor Necrosis Factor Alpha Antibodies Administered to Pregnant Women With Inflammatory Bowel Disease on Long-term Outcome of Exposed Children
- (2014) Martin Bortlik et al. INFLAMMATORY BOWEL DISEASES
- Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's Disease
- (2010) Kuldeep Cheent et al. Journal of Crohns & Colitis
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started